From 3D Cell Culture System to Personalized Medicine in Osteosarcoma - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Innovation in Tissue Engineering & Regenerative Medicine Année : 2019

From 3D Cell Culture System to Personalized Medicine in Osteosarcoma

Résumé

Osteosarcoma is the most common primary bone malignancy presenting typically during childhood and adolescence. However, few improvements of the survival outcomes for osteosarcoma patients have been achieved since the last three decades. Despite the rarity of the diagnosis, the complexity of tumor microenvironment and the genetic heterogeneity of osteosarcoma remain the major obstacles to understanding the mechanisms involved in tumor progression and metastasis, and to screening the pharmacologically active molecules for better drugs. Compared to the 2D cell culture system, 3D cell culture system is much closer to the in vivo physiological condition in tumor. Thus, 3D cell culture system could be a powerful technique to screen therapeutic agent towards personalized medicine in osteosarcoma.
Fichier principal
Vignette du fichier
view-3.pdf (367.8 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03891378 , version 1 (09-12-2022)

Identifiants

  • HAL Id : hal-03891378 , version 1

Citer

Fabien Bornert, Justine Gantzer, Jean-Emmanuel Kurtz, Natacha Entz-Werlé, Nadia Benkirane-Jessel, et al.. From 3D Cell Culture System to Personalized Medicine in Osteosarcoma. Innovation in Tissue Engineering & Regenerative Medicine, 2019, 1 (3). ⟨hal-03891378⟩

Collections

SITE-ALSACE
18 Consultations
17 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More